Volume 35, 10 September 2004 | 9/2004 |
SPOT ON | |
How do state authorities deal with illegal direct-to-consumer advertisement? | |
NEW ON THE MARKET | |
Basal insulin analog detemir (LEVEMIR) | |
BEWARE! MISSINFORMATION | |
Untrustworthy advertisement for chickenpox vaccine | |
THERAPIES FROM A CRITICAL VIEW POINT | |
CARD-study: atorvastatin (SORTIS) in diabetes? | |
REVIEW | |
Perioperative management of oral anticoagulation | |
a-t READERS' QUESTIONS AND COMMENTS | |
Methyl-aminolevulinate (METVIX) in basal cell carcinoma | |
IN BRIEF | |
Confirmed: compression stockings protect against post-thrombotic syndrome | |
CURRENT ADR NETWORK REPORT | |
Seizures with venlafaxine (TREVILOR) | |
SIDE EFFECTS | |
Fatal liver failure associated with pioglitazone (ACTOS) | |
© arznei-telegramm 9/2004 | ||